Urohealth Systems Results Again Delayed

Urohealth Systems Inc. on Monday again delayed the release of financial results for its fiscal year and promised analysts to discuss the results today in a conference call.

The stock of the Newport Beach biomedical company rose 78 cents a share Monday to close at $5.98 a share in Nasdaq trading--its first advance after four consecutive days of declines last week.

The company last week announced that earnings for its fiscal year ended March 31 would fall short of analysts’ projections of 47 cents a share. The company said that its accountants advised it that it couldn’t recognize $18 million in revenue--or 18% of its projected sales for the past year--in that period.

The company said last week that it expected to release results Monday, but executives couldn’t be reached Monday to comment on the further delay.